Skip to main navigation Skip to search Skip to main content

Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY

  • Yoon Koo Kang
  • , Hyung Don Kim
  • , Jeong Hwan Yook
  • , Young Kyu Park
  • , Jong Seok Lee
  • , Young Woo Kim
  • , Jin Young Kim
  • , Min Hee Ryu
  • , Sun Young Rha
  • , Ik Joo Chung
  • , In Ho Kim
  • , Sang Cheul Oh
  • , Young Soo Park
  • , Jae Ho Cheong
  • , Oh Jeong
  • , Mi Hwa Heo
  • , Hark Kyun Kim
  • , Cho Hyun Park
  • , Chang Hak Yoo
  • , Seok Yun Kang
    • Dae Young Zang, You Jin Jang, Ji Young Sul, Jong Gwang Kim, Beom Su Kim, Seung Hoon Beom, Jun Eul Hwang, Seung Wan Ryu, Myeong Cherl Kook, Baek Yeol Ryoo, Hyunki Kim, Moon Won Yoo, Nam Su Lee, Sang Ho Lee, Sung Hoon Noh
  • University of Ulsan
  • Chonnam National University
  • National Cancer Center Korea
  • Keimyung University
  • Yonsei University
  • Korea University
  • Catholic Univ. of Korea Coll. Med.
  • Sungkyunkwan University
  • Ajou University
  • Hallym University
  • Chungnam National University
  • Kyungpook National University
  • Soonchunhyang University
  • Kosin University

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science